Location History:
- San Francisco, CA (US) (2011)
- Copenhagen, DK (2011 - 2023)
Company Filing History:
4 out of 356 
3 out of 4 
2 out of 43 Years Active: 2011-2023
Title: Nils Jakob Vest Hansen: Innovator in Chemical Compound Binding
Introduction
Nils Jakob Vest Hansen is a prominent inventor based in Copenhagen, Denmark, known for his significant contributions to the field of chemical biology and molecular pharmacology. With a remarkable portfolio of 10 patents, Hansen has demonstrated a consistent drive for innovation and scientific advancement.
Latest Patents
Hansen's latest patents include two notable methods that showcase his expertise in the field. The first patent is entitled "Method for screening of an in vitro display library within a cell." This method pertains to screening an in vitro display library to identify small-molecule chemical compound binding entities. The aim is to determine which entities can effectively bind to specific protein or RNA targets within a cellular environment.
The second patent, "Method for making an enriched library," involves a technique for creating an enriched library that includes specific nucleic acid sequence information. This enables the identification of binding entities that attach to specific targets, enhancing the efficiency and specificity of in vitro display libraries.
Career Highlights
Throughout his career, Nils Jakob Vest Hansen has been affiliated with several esteemed organizations. He worked at GlaxoSmithKline LLC, a leading global healthcare company known for its research and development in pharmaceuticals, vaccines, and consumer health products. He also contributed his expertise at Vipergen Aps, a company focused on drug discovery and development.
Collaborations
Hansen has collaborated with notable professionals in his field, including Barry A. Morgan and Stephen Paul Hale. These collaborations have likely been instrumental in advancing his research and expanding the boundaries of chemical compound binding technologies.
Conclusion
Nils Jakob Vest Hansen continues to be a leading figure in innovation within the scientific community. His recent patents highlight his commitment to advancing our understanding of chemical interactions in biological systems. As he develops new methodologies, his work holds the promise of significant impacts in various applications, including drug discovery and development.